UPLOAD Filing
CYTOKINETICS INC
Date: Aug. 13, 2025 · CIK: 0001061983 · Accession: 0000000000-25-008487
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-50633
Letter
Re: Cytokinetics, Inc. Form 10-K for the fiscal year ended December 31, 2024 File No. 000-50633 Dear Sung Lee:
August 13, 2025
Sung Lee Executive Vice President and Chief Financial Officer Cytokinetics, Inc. 350 Oyster Point Blvd South San Francisco, CA 94080
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 13, 2025 Sung Lee Executive Vice President and Chief Financial Officer Cytokinetics, Inc. 350 Oyster Point Blvd South San Francisco, CA 94080 Re: Cytokinetics, Inc. Form 10-K for the fiscal year ended December 31, 2024 File No. 000-50633 Dear Sung Lee: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>